INSTITUTE FOR SYSTEMS BIOLOGY
Systems biology of intratumoral heterogeneity in glioblastoma
Systems biology of intratumoral heterogeneity in glioblastoma is a funding opportunity from INSTITUTE FOR SYSTEMS BIOLOGY, up to 735737, closing December 31, 2026.
Dec 31, 2026
(153d left)Overview
PROPOSAL SUMMARY (revisions in orange font ) Patients with glioblastoma (GBM) have a 12-14 month median survival rate, ~10% chance of 5-year survival, and ~90% likelihood of recurrence, even after receiving standard of care (SOC), which involves tumor resection, fractionated radiation therapy (XRT), and chemotherapy…